FDA is expected to approve GSK's new breast cancer drug, Tykerb, this week. GSK's Chief Operating Officer David Stout discusses the drug and new vaccines in its pipeline.
Bloomberg - (BLOOM)
Mar. 12, 2007. 04:32 PM EST
The COO discusses its new breast cancer drug as well as new vaccines in its pipeline.